Detalhe da pesquisa
1.
Appendiceal neuroendrocrine neoplasms: incidentaloma or something we should worry about?
Curr Opin Gastroenterol
; 36(1): 48-54, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31633562
2.
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
Br J Cancer
; 116(6): 742-751, 2017 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196064
3.
Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers.
BMC Cancer
; 15: 755, 2015 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490435
4.
Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer.
Future Oncol
; 11(12): 1775-89, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26075446
5.
Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.
Front Oncol
; 12: 835581, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280729
6.
Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study.
Cancer Rep (Hoboken)
; 5(10): e1571, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636178
7.
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.
ESMO Open
; 5(5): e000947, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978251
8.
Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy.
Clin Cancer Res
; 25(6): 1838-1850, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504427
9.
Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP.
Cancer Res
; 82(4): 734, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180309
10.
Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.
Sci Rep
; 7(1): 17452, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29234122
11.
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies.
Ther Adv Med Oncol
; 8(6): 429-449, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27800032
12.
Triple-negative breast cancer: treatment challenges and solutions.
Breast Cancer (Dove Med Press)
; 8: 93-107, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27284266
13.
Circulating microRNA-based screening tool for breast cancer.
Oncotarget
; 7(5): 5416-28, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26734993
14.
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.
Breast Cancer (Dove Med Press)
; 6: 43-57, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24833916
15.
EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.
Cancer Res
; 74(23): 6758-70, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25320013